REspiratory diSEAse cohoRt Studies of CHinese Medicine for Pneumonia (RESEARCH-Pneumonia)

Not yet recruitingOBSERVATIONAL
Enrollment

5,000

Participants

Timeline

Start Date

December 26, 2024

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2027

Conditions
Pneumonia
Interventions
DRUG

TCM

We will perform subgroup analyses based on specific TCM interventions (such as Chinese patent medicines or external therapies) and the duration of TCM treatment (for example, comparing patients who receive continuous oral Chinese patent medicine for two months or more each year with those who do not). These analyses will assess the efficacy and safety of TCM.

All Listed Sponsors
collaborator

Wuhan No.1 Hospital

OTHER

collaborator

Hebei Provincial Hospital of Traditional Chinese Medicine

OTHER_GOV

collaborator

Shanghai University of Traditional Chinese Medicine

OTHER

collaborator

Qingdao Hiser Medical Group

OTHER

collaborator

The First Affiliated Hospital of Zhejiang Chinese Medical University

OTHER

collaborator

Shaanxi Hospital of Traditional Chinese Medicine

OTHER

lead

Henan University of Traditional Chinese Medicine

OTHER

NCT06220019 - REspiratory diSEAse cohoRt Studies of CHinese Medicine for Pneumonia (RESEARCH-Pneumonia) | Biotech Hunter | Biotech Hunter